MDAI - Spectral AI Inc. Book Valuation of Business

This daily price chart for Spectral AI, Inc. (MDAI) illustrates the price action of an asset with a market capitalization of -0.01. Spectral AI, Inc. (MDAI) is scaling its DeepView system as it seeks FDA approval and aims to launch B2B sales. The business is expanding its reach by implementing AI diagnostics within the military sector and home care. The application of such technologies supports ESG goals by optimizing medication consumption and energy costs during patient examinations.

MDAI Spectral AI Book Capitalization (02/21/2024 - 10/27/2026)

Analytical breakdowns for Spectral AI (MDAI)

- price and consensus price forecast:

Stock Price spectral-ai.com|MDAI - Analyst Consensus Forecast

- market capitalization data:

Market Capitalization Spectral AI Inc.|MDAI - Enterprise Value

- book capitalization data:

Equity per Share Spectral AI|MDAI - Book Capitalization|Market Capitalization to Book Value spectral-ai.com|MDAI - Company Total Assets

- debt and liquidity data:

Total Debt to Capital Spectral AI, Inc.|MDAI - Long-Term Debt to Capital|Short-Term Indebtedness to Equity Spectral AI Inc.|MDAI - Company Debts|Debt to Book Value Ratio Spectral AI Inc.

Basic company analysis:spectral-ai.com - MDAI

Mass-produced product of Spectral AI, Inc.

Monitoring this metric minimizes risks by allowing an assessment of how effectively Spectral AI, Inc. (MDAI) deploys capital to develop the breakthrough DeepView system for deep tissue diagnostics. The trend in equity on the balance sheet reflects the difference between all assets and liabilities, demonstrating the real value of net assets and management's ability to scale AI technologies without a critical increase in debt.

Key competitors